Chimeric antigen receptor (CAR) T cell therapy has changed the treatment landscape for certain blood cancers. Standardizing CAR T cell manufacturing is one of the key considerations for improving production standards, reducing variability, and maximizing clinical safety and efficacy.
Download this article from Thermo Fisher Scientific to learn how closed, integrated, and automated instrument workflows improve CAR T cell manufacturing.